|
|
|
|
|
|
最高研发阶段临床2期 |
首次获批国家/地区- |
首次获批日期- |
A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain
The study consists of two parts. Part A will evaluate the safety and tolerability of intravenous LAT8881 in healthy volunteers using an ascending dose schedule. Part B will evaluate the analgesic efficacy of a single intravenous dose of LAT8881, compared with placebo, in patients with lumbar radicular pain.
Healthy volunteers are not accepted for Part B.
A proof of concept study of the efficacy and safety of oral LAT8881 in acute migraine
A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine
This is a randomised, placebo controlled, double blind, crossover proof of concept study to investigate the efficacy and safety of oral LAT8881 in acute migraine, with or without aura.
100 项与 Lateral Pharma Pty Ltd. 相关的临床结果
0 项与 Lateral Pharma Pty Ltd. 相关的专利(医药)
100 项与 Lateral Pharma Pty Ltd. 相关的药物交易
100 项与 Lateral Pharma Pty Ltd. 相关的转化医学